UCSF

ZINC19203131

Substance Information

In ZINC since Heavy atoms Benign functionality
October 28th, 2008 34 No

CAS Numbers: 1449-05-4 , 471-53-4 , [1449-05-4] , [471-53-4]

Other Names:

"Glycyrrhetinic acid, 97%"

(18alpha)-3beta-Hydroxy-11-oxoolean-12-en-30-oic acid

(2S,4aS,6aS,6bR,8aR,10S,12aS,12bR,14bR)-10-Hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydro-picene-2-carboxylic acid

(3-beta,20-beta)-3-Hydroxy-11-oxoolean-12-en-29-oic acid monoammonium salt; Ammonium glycyrrhetinate; LS-98307; Monoammonium glycyrrhetate; Monoammonium glycyrrhetinate; Olean-12-en-29-oic acid, 3-hydroxy-11-oxo-, monoammonium salt, (3-beta,20-beta)-; Ole

(3alpha,5xi,8alpha,9xi,17alpha,18xi)-3-hydroxy-11-oxoolean-12-en-29-oic acid; (3beta)-3-hydroxy-11-oxoolean-12-en-30-oic acid; (3beta,20beta)-3-Hydroxy-11-oxo-olean-12-en-29-oic acid; 18-beta-Glycyrrhetic acid; 18-beta-Glycyrrhetinic acid; 18beta-Glycyrrh

(3beta,18alpha,20beta)-3-Hydroxy-11-oxoolean-12-en-29-oic acid; 18-alpha-Olean-12-en-30-oic acid, 3-beta-hydroxy-11-oxo-; 18alpha-Glycyrrhetinic acid; 3-beta-Hydroxy-11-oxo-18-alpha-olean-12-en-30-oic acid; BRN 2956366; CCRIS 3963; EINECS 215-907-9; LS-98

olone

18 alpha-Glycyrrhetinic acid;18-Isoglycyrrhetinic acid;18a-Glycyrrhetic acid;18alpha-Olean-12-en-30-oic acid, 3beta-hydroxy-11-oxo- (6CI,7CI,8CI);3-Hydroxy-11-oxo-(3beta,18alpha,20beta)-Olean-12-en-29-oic acid;b-Glycyrrhetinic acid;beta-Glycyrrhetinic aci

18-a-Glycyrrhetinic Acid [1449-05-4]

18-a-GLYCYRRHETINIC ACID; [1449-05-4]

18-b-GLYCYRRHETINIC ACID

18-b-GLYCYRRHETINIC ACID; [471-53-4]

18-beta-Glycyrrhetinic acid, 98+%

18-Glycyrrhetinic acid [471-53-4]

18a-Glycyrrhetic acid

18a-Glycyrrhetinic acid

18alpha-Glycyrrhetic acid

18alpha-Glycyrrhetinic acid

18b-Glycyrrhetic acid

18b-Glycyrrhetic acid;18b-Glycyrrhetinic acid;18b-Glycyrrhtinic acid;3-Glycyrrhetinic acid;3-Hydroxy-11-oxoolean-12-en-29-oate;3-Hydroxy-11-oxoolean-12-en-29-oic acid;3-Hydroxy-11-oxoolean-12-en-29-oic acid (ACD/Name 4.0);3b-Hydroxy-11-oxo-Olean-12-en-30-

18beta-Glycyrrhetic acid

18beta-Glycyrrhetinic acid

18ý-Glycyrrhetic acid

3beta-Hydroxy-11-oxo-18beta,20beta-olean-12-en-29-oic acid

3beta-Hydroxy-11-oxoolean-12-en-30-oic acid

471-53-4; D00156; Enoxolone (INN); Glycyrrhetinic acid (JAN); Hidermart (TN)

Arthrodont

beta-Glycyrrhetinic acid

Biogastrone acid

Biosone

BRD-A20200672-001-02-2

BX-1

C02283; Enoxolone; Glycyrrhetinate; Glycyrrhetinic acid

CHEBI:24415; CHEBI:14366

DCF

DNC000697

DNC006674

DNC006675

Enoloxone

Enoxolone (BAN

Enoxolone (Glycyrrhetin)

Enoxolone, Glycyrrhetinic acid

Glycyrrhetic acid

Glycyrrhetin

Glycyrrhetin, Uralenic acid

glycyrrhetinate

Glycyrrhetinate; glycyrrhetinate

Glycyrrhetinic acid

GM-1658

INN

INN); Glycyrrhetic Acid (JAN)

MFCD00003706

MFCD00064897

MI

MI); Glycyrrhetic Acid (JAN)

NSC-35347

NSC-35347; NSC-35350

NSC-35350

Rhetinic acid

STX-352

Uralenic acid

Download: MOL2 SDF SMILES Flexibase

Annotations

Vendors

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) 5.62 11.48 -62.34 1 4 -1 77 469.686 1
Ref Reference (pH 7) 5.62 11.49 -61.44 1 4 -1 77 469.686 1
Lo Low (pH 4.5-6) 5.62 9.52 -14.08 2 4 0 75 470.694 1
Lo Low (pH 4.5-6) 5.62 9.52 -13.54 2 4 0 75 470.694 1

Vendor Notes

Note Type Comments Provided By
biological_use Antibacterial, antitussive agent ZereneX Building Blocks
mechanism . ZereneX Building Blocks
M.P 279-280C Indofine Natural Products
Mp [°C] 292 - 295 Acros Organics
M.P 292-295 °C Indofine Natural Products
MP 331-333°C Indofine
Purity 97% APIChem
biological_source Aglycone from Glycyrrhiza glabra and some other plants ZereneX Building Blocks
Indications anti-inflammatory KeyOrganics Bioactives
Indications antibacterial KeyOrganics Bioactives
biological_use Antibacterial, antitussive agent IBScreen Bioactives IBScreen Bioactives
biological_use Antiinflammatory IBScreen Bioactives
Therapy antitussive, antiinflammatory, antibacterial SMDC Pharmakon
mechanism Calcium-mobilizer in P815 cells in-vitro IBScreen Bioactives IBScreen Bioactives
Target Dehydrogenase Selleck Chemicals
PUBCHEM_PATENT_ID EP0069380A1; EP0081438A2; EP0087993A1; EP0093520A1; EP0100516A2; EP0156565A2; EP0156565B1; EP0179277A1; EP0212332A2; EP0220719A2; EP0255420A2; EP0269966A1; EP0269966B1; EP0272478A1; EP0272478B1; EP0272492A2; EP0272492B1; EP0275222A2; EP0277400A1; EP027740 IBM Patent Data
Target Others Selleck Chemicals
mechanism Reported to inhibit reactive oxygen species generation by human neutrophils in-vitro IBScreen Bioactives
mechanism Reported to trap hydroxyl radicals to suppress rat liver injury caused by ischemia-perfusion IBScreen Bioactives
S phrase S24/25: Avoid contact with skin and eyes. Acros Organics
biological_use Used in treatment of noninfective inflammatory disorders (skin, mouth, etc.) IBScreen Bioactives
APPEARANCE White powder Indofine Natural Products

Activity (Go SEA)

Clustered Target Annotations
Code Description Organism Class Affinity (nM) LE (kcal/mol/atom) Type
DHI1-2-E 11-beta-hydroxysteroid Dehydrogenase 1 (cluster #2 Of 3), Eukaryotic Eukaryotes 5 0.34 Binding ≤ 10μM
DHI2-1-E 11-beta-hydroxysteroid Dehydrogenase 2 (cluster #1 Of 2), Eukaryotic Eukaryotes 257 0.27 Binding ≤ 10μM
KPCL-1-E Protein Kinase C Eta (cluster #1 Of 4), Eukaryotic Eukaryotes 250 0.27 Binding ≤ 10μM
PTN11-2-E Protein-tyrosine Phosphatase 2C (cluster #2 Of 3), Eukaryotic Eukaryotes 9600 0.21 Binding ≤ 10μM
Z80418-3-O RAW264.7 (Monocytic-macrophage Leukemia Cells) (cluster #3 Of 9), Other Other 1300 0.24 Functional ≤ 10μM
ChEMBL Target Annotations
Uniprot Swissprot Description Affinity (nM) LE (kcal/mol/atom) Type
DHI1_RAT P16232 11-beta-hydroxysteroid Dehydrogenase 1, Rat 90 0.29 Binding ≤ 1μM
DHI1_MOUSE P50172 11-beta-hydroxysteroid Dehydrogenase 1, Mouse 10.58 0.33 Binding ≤ 1μM
DHI1_HUMAN P28845 11-beta-hydroxysteroid Dehydrogenase 1, Human 11.78 0.33 Binding ≤ 1μM
DHI2_HUMAN P80365 11-beta-hydroxysteroid Dehydrogenase 2, Human 257 0.27 Binding ≤ 1μM
DHI2_RAT P50233 11-beta-hydroxysteroid Dehydrogenase 2, Rat 360 0.27 Binding ≤ 1μM
KPCL_HUMAN P24723 Protein Kinase C Eta, Human 250 0.27 Binding ≤ 1μM
DHI1_MOUSE P50172 11-beta-hydroxysteroid Dehydrogenase 1, Mouse 10.58 0.33 Binding ≤ 10μM
DHI1_HUMAN P28845 11-beta-hydroxysteroid Dehydrogenase 1, Human 11.78 0.33 Binding ≤ 10μM
DHI1_RAT P16232 11-beta-hydroxysteroid Dehydrogenase 1, Rat 90 0.29 Binding ≤ 10μM
DHI2_HUMAN P80365 11-beta-hydroxysteroid Dehydrogenase 2, Human 257 0.27 Binding ≤ 10μM
DHI2_RAT P50233 11-beta-hydroxysteroid Dehydrogenase 2, Rat 360 0.27 Binding ≤ 10μM
KPCL_HUMAN P24723 Protein Kinase C Eta, Human 250 0.27 Binding ≤ 10μM
PTN11_HUMAN Q06124 Protein-tyrosine Phosphatase 2C, Human 9600 0.21 Binding ≤ 10μM
Z80418 Z80418 RAW264.7 (Monocytic-macrophage Leukemia Cells) 1300 0.24 Functional ≤ 10μM

Reactome Annotations from Targets (via Uniprot)

Description Species
Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon
Constitutive PI3K/AKT Signaling in Cancer
Costimulation by the CD28 family
CTLA4 inhibitory signaling
Downstream signal transduction
Effects of PIP2 hydrolysis
FRS2-mediated cascade
G alpha (z) signalling events
GAB1 signalosome
Glucocorticoid biosynthesis
Interferon alpha/beta signaling
Interleukin-3, 5 and GM-CSF signaling
Interleukin-6 signaling
Negative regulation of FGFR signaling
Netrin mediated repulsion signals
PD-1 signaling
PECAM1 interactions
PI-3K cascade
PI3K Cascade
PIP3 activates AKT signaling
Platelet sensitization by LDL
Prolactin receptor signaling
Regulation of IFNA signaling
Regulation of IFNG signaling
Signal regulatory protein (SIRP) family interactions
Signaling by Leptin
Signaling by SCF-KIT
Spry regulation of FGF signaling
Tie2 Signaling

Analogs ( Draw Identity 99% 90% 80% 70% )

No pre-computed analogs available. Try a structural similarity search.